Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

Kalijn F Bol, Thomas van den Bosch, Gerty Schreibelt, Hanneke W Mensink, Jan E E Keunen, Emine Kiliç, Wouter J Japing, Kaspar W Geul, Harm Westdorp, Steve Boudewijns, Sandra A J Croockewit, Michelle M van Rossum, Anna L de Goede, Nicole C Naus, Winette T A van der Graaf, Winald R Gerritsen, Annelies de Klein, Cornelis J A Punt, Carl G Figdor, Victoria M CohenDion Paridaens, I Jolanda M de Vries

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
Pages (from-to)2265-7
Number of pages3
JournalOphthalmology
Volume123
Issue number10
DOIs
Publication statusPublished - Oct 2016

Keywords

  • Adult
  • Aged
  • CD8-Positive T-Lymphocytes/immunology
  • Cancer Vaccines/administration & dosage
  • Dendritic Cells/immunology
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Melanoma/immunology
  • Middle Aged
  • Monophenol Monooxygenase/immunology
  • Survival Rate
  • Uveal Neoplasms/immunology
  • Vaccination
  • gp100 Melanoma Antigen/immunology

Cite this